SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-19-010203
Filing Date
2019-08-30
Accepted
2019-08-30 16:16:20
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tgtx_s3.htm S-3 241817
2 EXHIBIT 4.1 tgtx_ex41.htm EX-4 641605
3 EXHIBIT 5.1 tgtx_ex51.htm EX-5 39316
4 EXHIBIT 23.1 tgtx_ex231.htm EX-23 4037
5 IMAGE alstonlogo.jpg GRAPHIC 12944
6 IMAGE tgtx_s3000.jpg GRAPHIC 3698
7 IMAGE tgtx_s3001.jpg GRAPHIC 39423
  Complete submission text file 0001654954-19-010203.txt   1000211
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233565 | Film No.: 191069731
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences